Literature DB >> 2981399

A new approach to determine rates of receptor appearance and disappearance in vivo. Application to agonist-mediated down-regulation of rat renal cortical beta 1- and beta 2-adrenergic receptors.

M D Snavely, M G Ziegler, P A Insel.   

Abstract

We have developed a method for the assessment of agonist-induced down-regulation of receptors in vivo in terms of rates of receptor appearance and disappearance. This method involves computer-assisted analysis of the kinetics of receptor loss during agonist infusion and of the recovery of receptor number upon the removal of the agonist. These kinetics are analyzed in terms of a steady state model that allows estimation of the rate constants for receptor appearance, kappa ap, and receptor disappearance, kappa dp. Several tests establish that the model can fit experimentally derived data very well. In testing this model, we examined the in vivo down-regulation and recovery of rat renal cortical membrane beta 1- and beta 2-adrenergic receptors in response to infusion of the agonist isoproterenol from subcutaneously implanted osmotic minipumps. During recovery from down-regulation, the beta 1-receptors have a t 1/2 of 45 hr and a kappa ap of 1.6%/hr, and the beta 2-adrenergic receptors a t 1/2 of 18 hr and a kappa ap of 3.9%/hr. During down-regulation, the t 1/2 for both receptors is 12 hr, while kappa ap for beta 1-receptors and beta 2-receptors are 3 and 2.3%/hr, respectively. To the extent that the kinetics of recovery from down-regulation reflect "basal" receptor metabolism, the data indicate that enhanced receptor clearance of both receptor subtypes from the plasma membrane contribute to down-regulation, but changes in rates of receptor appearance may occur as well. The use of this computer modeling technique for defining kinetics of changes in receptor number from one steady state level to another should provide a generally useful means to assess hormone and neurotransmitter receptor metabolism in vivo.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981399

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

1.  In vivo regulation of beta-adrenergic receptors on mononuclear leukocytes and heart. Assessment of receptor compartmentation after agonist infusion and acute aortic constriction in guinea pigs.

Authors:  A S Maisel; M G Ziegler; S Carter; P A Insel; H J Motulsky
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

Review 2.  Beta-adrenoceptor responsiveness in hypertension: effects of dietary NaCl intake.

Authors:  R D Feldman
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

3.  Structural basis of antifolate recognition and transport by PCFT.

Authors:  Joanne L Parker; Justin C Deme; Gabriel Kuteyi; Zhiyi Wu; Jiandong Huo; I David Goldman; Raymond J Owens; Philip C Biggin; Susan M Lea; Simon Newstead
Journal:  Nature       Date:  2021-05-26       Impact factor: 49.962

4.  Acceleration by chronic treatment with clorgyline of the turnover of brain alpha 2-adrenoceptors in normotensive but not in spontaneously hypertensive rats.

Authors:  C Ribas; A Miralles; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

5.  Rapid and reversible desensitisation of vascular and platelet alpha 2 adrenoceptors.

Authors:  C A Hamilton; N M Deighton; J L Reid
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

6.  Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1-, beta 1- and beta 2-receptor-mediated responses.

Authors:  S W Martin; K J Broadley
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

7.  Salbutamol induced hypokalaemia: the effect of theophylline alone and in combination with adrenaline.

Authors:  K F Whyte; C Reid; G J Addis; R Whitesmith; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1988-05       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.